Non-invasive uveitis screening, diagnosis
Kriba has developed a non-invasive, automatic, AI-powered white blood cell counter that enables worldwide access to accurate screening, diagnosis, monitoring of uveitis, and objective quantification of the disease severity on closed eyelids.
This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.
Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of uveitis
Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness.
Suspecting uveitis can be challenging because it can present asymptomatically in children and infants with juvenile idiopathic arthritis. Uveitis is also missed by the non-expert clinicians in cases of red eye and conjunctivitis, leading to delayed referrals to specialists. Accurate treatment monitoring is also paramount to avoid clinical complications. This is why accurate and objective quantification of the disease severity is needed.
Due to similarities with other ocular condition, misdiagnosis or delayed treatment is possible, moreover, uveitis is often associated with systemic diseases or infections making diagnosis complex.
Low and middle income regions may also have limited access to advanced diagnostic tools and specialized expertise. This can affect timely and accurate detection of uveitis.
The device will allow the exploration of patients with specific conditions that were difficult to examine before. Its ubiquity in the health system, especially in eye care units, emergency departments and primary care, will improve early detection of uveitis. This will lead to reduced treatment costs and lower rates of blindness and vision loss associated with uveitis.
Measurements on closed eyelid for patient comfort and probe placement system to switch from eye to eye.
Automated cell count measurement
powered by AI
Sensitivity and accuracy
High sensitivity and specificity to accurately screen, diagnose and monitor, especially for patients with nonspecific clinical presentations.
It can be used to perform frequent measurements to track white blood cell count evolution, to monitor the patient’s response to treatment.
Early detection will save costs associated to unnecessary laboratory tests, treatments, hospitalization.
Novelties flourishing in the infant care
Kriba Eye care
Introducing non-invasive and automatic early detection and quantitative monitoring of uveitis.
Stay in touch
Want to know about our project updates and latest news?
The content featured on this site is exclusively addressed to healthcare and medical technology specialists. The following products are under development and/or validation processes and they are not ready for commercialization.